Study Overview: This clinical research is comparing two eye drops, NCX 470 and latanoprost, to see how well they lower eye pressure in people with open-angle glaucoma or ocular hypertension. Glaucoma is an eye disease where pressure inside the eye is too high and can harm vision. Ocular hypertension means the eye pressure is higher than normal but hasn't yet damaged vision. The study lasts for up to 12 months, with participants using the eye drops once daily in the evening.
Eligibility:- You must have open-angle glaucoma or ocular hypertension in both eyes.
- You cannot have had recent eye surgeries or severe eye injuries.
- You should not have any other serious eye or health problems.
Key Points:
- The study lasts up to 12 months with daily eye drop use.
- Participants are randomly put into two groups to test different eye drops.
- Eligibility requires specific eye condition and health criteria.
How understandable was the trial content above?
Hard to understand
Easy to understand